v3 Template
A

Absci Corporation

Biotechnology Vancouver, Wash. ~500 employees
Founded
--
Employees (Est.)
~500
25 leaders known
Total Funding
$286.6M
Funding Rounds
4
Last Funding
2025-07-24

About Absci Corporation

Absci is a company focused on creating better biologics for patients using generative AI. Their mission is to uncover novel biology and design differentiated biologics faster, addressing the historically long and expensive process of biologics drug discovery to ultimately deliver life-changing medicines.

Products & Services

Integrated Drug Creation Platform:A platform that uses AI to design differentiated biologics, such as a TL1A antibody for Inflammatory Bowel Disease with a potential best-in-class profile.
AI Target Discovery:AI-enabled technology for novel target discovery using Reverse Immunology to identify antibodies from super immune responders, ready for optimization and studies.
Pipeline Programs:A robust pipeline of internal and partnered programs designed with generative AI to develop biologics against challenging targets.

Specialties

Generative AI for Drug Creation Biologics Design Target Discovery using Reverse Immunology Multi-parametric Lead Optimization

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering
A: 50000000
MR: -
FA: $50 million
FAN: 50000000
D: 2025-07-24
FD: 2025-07-24
4 investors
2 RT: Public Offering
T: -
FT: Public Offering
A: 86400000
MR: -
FA: 86.4 million
FAN: 86400000
D: 2024-03-01
FD: 2024-03-01
2 investors
3 RT: Public Offering
T: -
FT: Public Offering
A: 75000000
MR: -
FA: $75.0 million
FAN: 75000000
D: 2024-02-27
FD: 2024-02-27
2 investors
4 RT: Public Offering
T: -
FT: Public Offering
A: 75200000
MR: -
FA: approximately $75.2 million
FAN: 75200000
D: 2024-02-27
FD: 2024-02-27
2 investors
Public Offering Latest
2025-07-24
$50.0M
4 investors (Pro only)
Public Offering 2024-03-01
$86.4M
Public Offering 2024-02-27
$75.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Sean McClain

Founder, CEO & Director

Z

Zach Jonasson

Chief Financial Officer & Chief Business Officer

A

Andreas Busch

Chief Innovation Officer

S

Shelby Walker

Chief Legal Officer

K

Karin Wierinck

Chief People Officer

A

Amir Shanehsazzadeh

Chief AI Officer

View 22 more team members with Pro

Unlock Full Team Directory

Recent News

Absci Corporation Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
absci.com
Industries
Biotechnology
Company Size
~500 employees (est.)
Locations
Vancouver, Wash.
Vancouver, Wash. and Boston, USA
Vancouver, WA and New York, USA +2 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro